U.S. Chemicals Stock News

NasdaqCM:REAX
NasdaqCM:REAXReal Estate

3 Penny Stocks With Market Caps Over $800M To Consider

Major stock indexes in the United States recently ended lower as investors weighed earnings reports and ongoing U.S.-China trade tensions. In such a fluctuating market, penny stocks—despite their somewhat outdated moniker—remain a compelling area for investment, particularly when they are backed by solid financials. These smaller or newer companies can offer surprising value and potential for growth, making them worth considering for investors seeking hidden opportunities in quality stocks.
NYSE:HMN
NYSE:HMNInsurance

Discovering US Undiscovered Gems This October 2025

In October 2025, the U.S. stock market has been navigating a complex landscape marked by renewed U.S.-China trade tensions and mixed earnings reports, leading to declines in major indices such as the Nasdaq, Dow Jones Industrial Average, and S&P 500. Amidst this backdrop of uncertainty and fluctuating investor sentiment, identifying promising small-cap stocks can offer unique opportunities for those looking to uncover potential growth avenues in less-explored corners of the market.
NYSE:HY
NYSE:HYMachinery

3 Dividend Stocks Yielding Up To 3.8% For Your Investment Strategy

As the U.S. stock market grapples with earnings reports and renewed U.S.-China trade tensions, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have ended lower. In such uncertain times, dividend stocks can offer a reliable income stream for investors seeking stability amidst market volatility.
NasdaqCM:VSTM
NasdaqCM:VSTMBiotechs

Verastem (VSTM) Advances KRAS G12D Program—Could Early-Stage Data Redefine Its Oncology Roadmap?

Earlier this week, Verastem Oncology announced promising preliminary data from the Phase 1/2a clinical trial of VS-7375, an oral KRAS G12D inhibitor, in patients with advanced KRAS G12D mutant solid tumors, along with the initiation of a combination cohort with cetuximab. These findings are significant, as there are currently no FDA-approved therapies specifically targeting KRAS G12D mutations in cancer, addressing a critical gap for patients with limited treatment options. We'll explore how...
NasdaqGS:ASPS
NasdaqGS:ASPSReal Estate

Altisource Portfolio Solutions (ASPS): Losses Down 33.9% Annually, Deep Valuation Discount Spurs Debate

Altisource Portfolio Solutions (ASPS) remains unprofitable but has managed to reduce its annual losses by 33.9% per year over the past five years. While the company’s net income has not turned positive and profit growth has not accelerated recently, its Price-To-Sales Ratio of 0.8x stands well below the peer average of 3.4x and the US Real Estate sector average of 2.6x. Investor attention is likely to center on operational progress and revenue momentum, even as shareholder dilution and...
NYSE:NLY
NYSE:NLYMortgage REITs

Annaly Capital Management (NLY) Earnings Growth Forecast Surpasses US Market, Underscoring Bull Case

Annaly Capital Management (NLY) just posted forecasts pointing to annual earnings growth of 28.07% and revenue set to climb by 21.8% each year, both comfortably ahead of US market averages. The company became profitable over the past year, with net profit margins improving during the period. For investors, strong growth prospects and a track record of high-quality earnings are balanced by some caution around financial stability and dividend sustainability. See our full analysis for Annaly...
NYSE:MRC
NYSE:MRCTrade Distributors

Assessing MRC Global (MRC) Valuation: Is There Still Upside After Recent Gains?

MRC Global (MRC) has recently drawn attention as investors look for value plays in the industrial sector. The stock’s performance over the past year has shown a positive trend, and participants are closely watching for shifts in market sentiment. See our latest analysis for MRC Global. The momentum around MRC Global is building as the stock’s share price has climbed steadily so far in 2024, with a notable 10.3% year-to-date share price return. Over the past year, total shareholder return sits...
NasdaqCM:HSDT
NasdaqCM:HSDTMedical Equipment

Solana (HSDT): Assessing Valuation After Resale Registration Sparks Heavy Selloff and Elevated Trading Activity

Solana (HSDT) triggered fresh attention this week by making its resale registration effective. This move unlocked previously restricted shares for early investors after a sizable private placement. The result was an immediate spike in trading activity and pronounced price movement. See our latest analysis for Solana. While broader markets have been steady, Solana’s shares took a dramatic turn after unlocking private investor shares, triggering a 60% drop in the past week alone. That sharp...
OTCPK:TSPH
OTCPK:TSPHTransportation

Undervalued Penny Stocks To Watch In October 2025

As the U.S. stock market experiences gains amid trade news with China and a surge in oil futures, investors are keeping a close eye on emerging opportunities. Penny stocks, despite their somewhat outdated label, remain an intriguing area for those interested in smaller or newer companies that might offer untapped potential. These stocks can provide growth opportunities at lower price points when supported by strong financials and sound fundamentals.
NasdaqGM:SPWR
NasdaqGM:SPWRElectrical

A Look at SunPower (SPWR) Valuation After Strong Q3 Results and Major Strategic Expansion

SunPower (SPWR) just reported its Q3 results, beating expectations on both revenue and operating income. The company is also making moves by acquiring Sunder Energy and doubling its dealer salesforce. See our latest analysis for SunPower. SunPower’s shares have seen some recovery lately, with a 30-day share price return of nearly 7% and a 9% bump over the last 90 days. This follows upbeat earnings and notable moves such as changing its name and doubling its distribution network. Still,...